B-type natriuretic peptide for assessment of haemodynamically significant patent ductus arteriosus in premature infants

Abstract
Aim: Haemodynamically significant patent ductus arteriosus (hsPDA) is frequently observed in premature infants. This study was conducted to explore whether the blood BNP can be a valuable biomarker to assess the necessity of treatment for hsPDA in premature infants.
Funding Information
  • Mami Mizutani foundation
  • Human Resource Chair